Primary myelofibrosis-related glomerulopathy with renal extramedullary hematopoiesis.
作者信息
Kim Hyo Jeong, Jung Minsun, Lim Beom Jin, Cheong June-Won, Han Seung Hyeok
机构信息
Department of Internal Medicine, Yonsei University College of Medicine, Institute of Kidney Disease Research, 50 Yonsei-Ro, Seodaemun-Gu, Seoul, 03722, Republic of Korea.
Division of Nephrology, Department of Internal Medicine, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul, South Korea.
出版信息
J Nephrol. 2023 Nov;36(8):2387-2390. doi: 10.1007/s40620-023-01621-z. Epub 2023 Apr 17.
PMID:37067698
Abstract
摘要
相似文献
1
Primary myelofibrosis-related glomerulopathy with renal extramedullary hematopoiesis.
J Nephrol. 2023 Nov;36(8):2387-2390. doi: 10.1007/s40620-023-01621-z. Epub 2023 Apr 17.
2
Extramedullary haematopoiesis in the kidney: a case report and review of literature.
Clin Lab Haematol. 2005 Dec;27(6):391-4. doi: 10.1111/j.1365-2257.2005.00724.x.
3
Renal myelofibrosis: an unusual cause of renal impairment.
Nephrol Dial Transplant. 2000 Feb;15(2):257-8. doi: 10.1093/ndt/15.2.257.
4
Massive ascites caused by peritoneal extramedullary hematopoiesis as the initial manifestation of myelofibrosis.
Am J Med Sci. 1999 Sep;318(3):198-200. doi: 10.1097/00000441-199909000-00017.
5
Intestinal obstruction caused by extramedullary hematopoiesis and ascites in primary myelofibrosis.
World J Gastroenterol. 2014 Sep 7;20(33):11921-6. doi: 10.3748/wjg.v20.i33.11921.
6
Extramedullary peritoneal hematopoiesis combined with tuberculosis in a patient with primary myelofibrosis.
Med Oncol. 2009;26(2):238-41. doi: 10.1007/s12032-008-9099-2. Epub 2008 Oct 11.
7
Extramedullary Hematopoiesis of the Renal Pelvis in a Patient With Myelofibrosis.
J Oncol Pract. 2019 Aug;15(8):458-459. doi: 10.1200/JOP.19.00041. Epub 2019 Jun 17.
8
[Idiopathic myelofibrosis with cutaneous extramedullary hematopoiesis].
Med Clin (Barc). 1991 Jun 1;97(1):24-6.
9
Spinal cord compression due to extramedullary haemopoiesis in myelofibrosis.
J Clin Pathol. 1994 May;47(5):464-5. doi: 10.1136/jcp.47.5.464.
10
Hepatic nodule: a case of primary myelofibrosis.
BMJ Case Rep. 2011 Aug 4;2011:bcr0520114220. doi: 10.1136/bcr.05.2011.4220.
本文引用的文献
1
Primary myelofibrosis: 2021 update on diagnosis, risk-stratification and management.
Am J Hematol. 2021 Jan;96(1):145-162. doi: 10.1002/ajh.26050. Epub 2020 Dec 2.
2
Renal disease associated with myeloproliferative neoplasms and myelodysplastic syndrome/myeloproliferative neoplasms.
Histopathology. 2021 Apr;78(5):738-748. doi: 10.1111/his.14282. Epub 2020 Dec 14.
3
Renal extramedullary hematopoiesis: interstitial and glomerular pathology.
Mod Pathol. 2015 Dec;28(12):1574-83. doi: 10.1038/modpathol.2015.117. Epub 2015 Oct 9.
4
Myeloproliferative neoplasms cause glomerulopathy.
Kidney Int. 2011 Oct;80(7):753-9. doi: 10.1038/ki.2011.147. Epub 2011 Jun 8.
5
Effects of TGF-beta on podocyte growth and disease progression in proliferative podocytopathies.
Kidney Blood Press Res. 2010;33(1):24-9. doi: 10.1159/000285844. Epub 2010 Feb 23.
6
A new look at platelet-derived growth factor in renal disease.
J Am Soc Nephrol. 2008 Jan;19(1):12-23. doi: 10.1681/ASN.2007050532. Epub 2007 Dec 12.
7
The myeloproliferative disorders.
N Engl J Med. 2006 Dec 7;355(23):2452-66. doi: 10.1056/NEJMra063728.
8
Apoptosis in podocytes induced by TGF-beta and Smad7.
J Clin Invest. 2001 Sep;108(6):807-16. doi: 10.1172/JCI12367.
9
Focal segmental glomerulosclerosis and mesangial sclerosis associated with myeloproliferative disorders.
Am J Kidney Dis. 1999 Nov;34(5):889-93. doi: 10.1016/S0272-6386(99)70047-8.
Zotero 插件